Indaptus Therapeutics, Inc. (INDP)
3.13
+0.13
(+4.33%)
USD |
NASDAQ |
Jan 09, 16:00
3.10
-0.03
(-0.96%)
After-Hours: 20:00
Indaptus Therapeutics EPS Diluted (Quarterly): -2.984 for Sept. 30, 2025
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Dynavax Technologies Corp. | 0.2063 |
| Citius Pharmaceuticals, Inc. | -0.4405 |
| Applied Therapeutics, Inc. | -0.1305 |
| Dermata Therapeutics, Inc. | -1.648 |
| CEL-SCI Corp. | -0.7611 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -2.975M |
| Total Expenses (Quarterly) | 2.975M |
| Enterprise Value | -4.024M |
| Earnings Yield | -729.5% |
| Normalized Earnings Yield | -690.66 |